We were thrilled to see NeoPancONE, funded exclusively by our Canadian donors, showcased at the recent 2025 American Society of Clinical Oncology (ASCO) conference in Chicago. It was one of the most anticipated presentations spotlighting the progress being made...
Dr. Eugene Koay, Associate Professor in the Department of Gastrointestinal Radiation Oncology at The University of Texas MD Anderson Cancer Center, is the lead researcher on an innovative study funded by Pancreatic Cancer Canada that is harnessing artificial...
The project will be funded as part of our $5 million commitment to fund research into early detection and screening New York – July 2024 Pancreatic cancer is the world’s toughest cancer – the 5-year relative survival rate is just over 10 percent. Most pancreatic...
Recent Comments